An update on access to novel treatment for metastatic melanoma in Europe — A 2024 survey of the European melanoma registry and the European association of dermato-oncology
Year: 2024
Type: article
Study design: Observational Study
Source: European Journal of Cancer
Authors: L. Kandolf, P.A. Ascierto, L. Bastholt, I. Gavrilova, J. Haanen, A. Hauschild, D. Herceg, C. Hoeller, A. Jalovcic Suljevic, JI Kessels, I. Krajsova, M. Kukushkina, A. Lallas, P. Lorigan, J. Mangana, I. Marquez-Rodas, L. Mazilu, P. Mohr, M. Bylaite-Bucinskiene, J. Ocvirk, J. Olah, K. Putnik, P. Rutkowski, P. Saiag, I. Samolyenko, J.K. Schwarze, I. Stojkovski, N. Cicmil Sarić, R. Vieira, M. Weichenthal, C. Garbe
Institutions: Military Medical Academy, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Odense University Hospital, The Netherlands Cancer Institute, University Hospital Schleswig-Holstein, University Hospital Centre Zagreb, Medical University of Vienna, Clinical Center University of Sarajevo, Universitair Ziekenhuis Brussel, General University Hospital in Prague, Aristotle University of Thessaloniki, University of Manchester, The Christie NHS Foundation Trust, University Hospital Zurich, Hospital General Universitario Gregorio Marañón, Elbe Kliniken Stade-Buxtehude, Vilnius University, University of Ljubljana, Institute of Oncology Ljubljana, University of Szeged, North Estonia Medical Centre, The Maria Sklodowska-Curie National Research Institute of Oncology, Université de Versailles Saint-Quentin-en-Yvelines, Université Paris-Saclay, Hôpital Ambroise-Paré, Russian Cancer Research Center NN Blokhin, University Clinic for Radiotherapy and Oncology, Ss. Cyril and Methodius University in Skopje, University of Coimbra, Universitätsklinikum Tübingen
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4404436737